When we analysed the DFS of patients with ERα-negative tumours according to ERα/Src intensity staining in a Duolink experiment (0 vs. 1–2), we identified a subpopulation of patients that did not display oestrogen non-genomic signalling and who did not relapse (Supporting Information Fig S8). Here, SRC is linked to neoplasm.